InvestorsHub Logo
Followers 15
Posts 1464
Boards Moderated 0
Alias Born 01/06/2010

Re: None

Thursday, 12/29/2016 11:58:53 PM

Thursday, December 29, 2016 11:58:53 PM

Post# of 8449
Waiting for KTOV to be like TBRA. :)

"Allergan plc (NYSE: AGN) and Tobira Therapeutics, Inc. (NASDAQ: TBRA), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for non-alcoholic steatohepatitis (NASH) and other liver diseases, today announced that they have entered into a definitive agreement under which Allergan will acquire Tobira for an upfront payment of $28.35 per share, in cash, and up to $49.84 per share in Contingent Value Rights (CVRs) that may be payable based on the successful completion of certain development, regulatory and commercial milestones, for a total potential consideration of up to $1.695 billion. The Boards of Directors of both companies have unanimously approved the transaction."